Facebook
Twitter
Telegram
Report an ErrorscPharmaceuticals Financial Ratios 2011-2024 | SCPH
Annual Financial Ratios scPharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-3.8 | -5.4 | -4.2 | -5.4 | -3.4 | -2.4 | -1.6 | - | - | - | - | - | - |
P/S |
15.4 | - | - | - | - | - | - | - | - | - | - | - | - |
EPS |
-1.4 | -1.3 | -1.0 | -1.3 | -1.8 | -1.6 | -8.0 | -25.0 | - | - | - | - | - |
EV (Enterprise Value) |
220 M | 181 M | 66.2 M | 128 M | 65.5 M | -4.88 M | -66.4 M | 76.8 M | 20.1 M | - | - | - | - |
EBITDA per Share |
-1.44 | -1.27 | -0.94 | -1.09 | -1.75 | -1.58 | -7.76 | - | - | - | - | - | - |
EV/EBITDA |
-2.2 | -3.5 | -1.8 | 0.3 | 3.1 | - | - | - | - | - | - | ||
PEG |
-2.51 | 0.32 | - | -0.16 | 0.3 | -0.03 | 0.05 | - | - | - | - | - | - |
P/B |
5.6 | 2.8 | 2.1 | 2.1 | 2.2 | 0.9 | 0.4 | - | - | - | - | - | - |
P/CF |
-3.5 | -5.8 | -4.3 | -6.3 | -3.7 | -2.4 | -1.7 | - | - | - | - | - | - |
ROE % |
-147.27 | -50.86 | -49.64 | -39.20 | -64.24 | -37.39 | -22.47 | - | - | - | - | - | - |
ROA % |
-58.01 | -29.66 | -35.47 | -29.54 | -42.70 | -31.40 | -19.80 | - | - | - | - | - | - |
ROCE % |
-148.84 | -49.92 | -45.73 | -30.01 | -45.67 | -34.07 | -20.33 | - | - | - | - | - | - |
Current Ratio |
1.6 | 2.4 | 3.5 | 11.6 | 14.4 | 13.8 | 24.1 | - | - | - | - | - | - |
DSO |
60.3 | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
482.2 | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
264.3 | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
542.5 | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
278.2 | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios scPharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.36 | - | -0.41 | -0.36 | -0.3 | - | -0.37 | -0.35 | -0.28 | - | -0.24 | -0.26 | -0.26 | - | -0.33 | -0.36 | -0.35 | - | -0.33 | -0.39 | -0.47 | - | -0.31 | -0.53 | -0.47 | - | -5.08 | -6.09 | -4.59 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.41 | - | -0.38 | -0.36 | -0.31 | - | -0.36 | -0.34 | -0.26 | - | -0.22 | -0.24 | -0.25 | - | -0.31 | -0.33 | -0.33 | - | -0.34 | -0.39 | -0.48 | - | -0.31 | -0.53 | -0.47 | - | -4.85 | -6.07 | -4.63 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-143.37 | -68.91 | -101.58 | -102.43 | -104.09 | -72.29 | -82.67 | -60.38 | -46.64 | -30.02 | -41.01 | -41.63 | -41.50 | -29.72 | -41.81 | -42.89 | -46.92 | -43.18 | -50.50 | -45.73 | -44.12 | -30.91 | -36.09 | -33.95 | -27.61 | -15.98 | -15.98 | -10.80 | -4.63 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-59.85 | -35.93 | -56.93 | -63.19 | -67.18 | -48.61 | -56.09 | -42.58 | -33.74 | -22.11 | -30.40 | -31.20 | -31.26 | -22.40 | -30.43 | -30.17 | -31.95 | -28.70 | -34.85 | -32.96 | -34.08 | -25.96 | -30.46 | -28.81 | -23.66 | -13.88 | -13.88 | -9.38 | -4.02 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-146.60 | -67.11 | -99.24 | -101.17 | -102.78 | -70.07 | -79.43 | -56.66 | -42.72 | -27.63 | -37.90 | -38.82 | -38.81 | -27.70 | -39.95 | -41.92 | -46.86 | -43.75 | -51.17 | -46.34 | -44.64 | -31.04 | -36.00 | -33.53 | -27.10 | -15.78 | -15.78 | -10.83 | -4.68 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.5 | 1.6 | 1.9 | 2.2 | 2.5 | 2.4 | 2.8 | 3.2 | 3.5 | 3.5 | 3.6 | 3.8 | 4.0 | 4.1 | 4.1 | 4.1 | 4.1 | 3.0 | 3.0 | 3.0 | 3.0 | 6.2 | 6.2 | 6.2 | 6.2 | 7.6 | 7.6 | 7.6 | 7.6 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
76.7 | - | 69.5 | 128.5 | 66.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
470.6 | - | 547.8 | 1218.3 | 365.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
171.4 | - | 192.5 | 361.9 | 237.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
547.3 | - | 617.3 | 1346.9 | 432.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
375.9 | - | 424.9 | 985.0 | 195.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency